FDA approved Mounjaro to lower the risk of heart attack, stroke, and cardiovascular death in adults with type 2 diabetes at high risk.
Mounjaro Can Now Be Prescribed to Lower Heart Attack and Stroke Risk in Adults with Type 2 Diabetes
by | Aug 29, 2026 | Uncategorized | 0 comments

Recent Comments